ID   BIRC6_HUMAN             Reviewed;        4857 AA.
AC   Q9NR09; Q9ULD1;
DT   24-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2010, sequence version 2.
DT   25-APR-2018, entry version 165.
DE   RecName: Full=Baculoviral IAP repeat-containing protein 6;
DE            EC=2.3.2.27 {ECO:0000269|PubMed:14765125, ECO:0000269|PubMed:18329369};
DE   AltName: Full=BIR repeat-containing ubiquitin-conjugating enzyme;
DE            Short=BRUCE;
DE   AltName: Full=RING-type E3 ubiquitin transferase BIRC6 {ECO:0000305};
DE   AltName: Full=Ubiquitin-conjugating BIR domain enzyme apollon;
DE            Short=APOLLON;
GN   Name=BIRC6; Synonyms=KIAA1289;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 29-4857.
RC   TISSUE=Brain;
RX   PubMed=10544019; DOI=10.1006/bbrc.1999.1585;
RA   Chen Z., Naito M., Hori S., Mashima T., Yamori T., Tsuruo T.;
RT   "A human IAP-family gene, apollon, expressed in human brain cancer
RT   cells.";
RL   Biochem. Biophys. Res. Commun. 264:847-854(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2063-4857.
RC   TISSUE=Brain;
RX   PubMed=10574462; DOI=10.1093/dnares/6.5.337;
RA   Nagase T., Ishikawa K., Kikuno R., Hirosawa M., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XV.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:337-345(1999).
RN   [4]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [5]
RP   INTERACTION WITH RNF41, UBIQUITINATION, FUNCTION, AND CATALYTIC
RP   ACTIVITY.
RX   PubMed=14765125; DOI=10.1038/sj.emboj.7600075;
RA   Qiu X.B., Markant S.L., Yuan J., Goldberg A.L.;
RT   "Nrdp1-mediated degradation of the gigantic IAP, BRUCE, is a novel
RT   pathway for triggering apoptosis.";
RL   EMBO J. 23:800-810(2004).
RN   [6]
RP   FUNCTION, SUBUNIT, ENZYME REGULATION, DOMAIN BIR, AND INTERACTION WITH
RP   HTRA2; CASP3; CASP6; CASP7; CASP9 AND DIABLO/SMAC.
RX   PubMed=15200957; DOI=10.1016/j.molcel.2004.05.018;
RA   Bartke T., Pohl C., Pyrowolakis G., Jentsch S.;
RT   "Dual role of BRUCE as an antiapoptotic IAP and a chimeric E2/E3
RT   ubiquitin ligase.";
RL   Mol. Cell 14:801-811(2004).
RN   [7]
RP   REVIEW ON FUNCTION.
RX   PubMed=15340445; DOI=10.1038/ncb0904-804;
RA   Martin S.J.;
RT   "An Apollon vista of death and destruction.";
RL   Nat. Cell Biol. 6:804-806(2004).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, PHOSPHORYLATION,
RP   UBIQUITINATION, DEUBIQUITINATION, AND INTERACTION WITH KIF23/MKLP1;
RP   USP8/UBPY; BIRC5/SURVIVIN; MAP2K1/MEK1; RAB8A/RAB8; RAB11A/RAB11;
RP   PLK1; EXOC3/SEC6 AND EXOC4/SEC8.
RX   PubMed=18329369; DOI=10.1016/j.cell.2008.01.012;
RA   Pohl C., Jentsch S.;
RT   "Final stages of cytokinesis and midbody ring formation are controlled
RT   by BRUCE.";
RL   Cell 132:832-845(2008).
RN   [10]
RP   REVIEW ON FUNCTION.
RX   PubMed=18414036; DOI=10.4161/cc.7.8.5783;
RA   Dubrez-Daloz L., Dupoux A., Cartier J.;
RT   "IAPs: more than just inhibitors of apoptosis proteins.";
RL   Cell Cycle 7:1036-1046(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-480, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-480, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-480, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-480; SER-581; SER-590;
RP   SER-2222; SER-2955; THR-3931 AND SER-4023, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-480 AND THR-1710, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.01 ANGSTROMS) OF 4498-4820.
RG   Structural genomics consortium (SGC);
RT   "Ubc domain of the ubiquitin-protein ligase baculoviral IAP repeat-
RT   containing protein 6.";
RL   Submitted (APR-2008) to the PDB data bank.
RN   [20] {ECO:0000244|PDB:3CEG}
RP   X-RAY CRYSTALLOGRAPHY (2.01 ANGSTROMS) OF 4498-4820.
RX   PubMed=22496338; DOI=10.1074/mcp.O111.013706;
RA   Sheng Y., Hong J.H., Doherty R., Srikumar T., Shloush J.,
RA   Avvakumov G.V., Walker J.R., Xue S., Neculai D., Wan J.W., Kim S.K.,
RA   Arrowsmith C.H., Raught B., Dhe-Paganon S.;
RT   "A human ubiquitin conjugating enzyme (E2)-HECT E3 ligase structure-
RT   function screen.";
RL   Mol. Cell. Proteomics 11:329-341(2012).
CC   -!- FUNCTION: Anti-apoptotic protein which can regulate cell death by
CC       controlling caspases and by acting as an E3 ubiquitin-protein
CC       ligase. Has an unusual ubiquitin conjugation system in that it
CC       could combine in a single polypeptide, ubiquitin conjugating (E2)
CC       with ubiquitin ligase (E3) activity, forming a chimeric E2/E3
CC       ubiquitin ligase. Its tragets include CASP9 and DIABLO/SMAC. Acts
CC       as an inhibitor of CASP3, CASP7 and CASP9. Important regulator for
CC       the final stages of cytokinesis. Crucial for normal vesicle
CC       targeting to the site of abscission, but also for the integrity of
CC       the midbody and the midbody ring, and its striking ubiquitin
CC       modification. {ECO:0000269|PubMed:14765125,
CC       ECO:0000269|PubMed:15200957, ECO:0000269|PubMed:18329369}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine. {ECO:0000269|PubMed:14765125,
CC       ECO:0000269|PubMed:18329369}.
CC   -!- ENZYME REGULATION: Inhibited by DIABLO/SMAC, HTRA2, CASP3, CASP6,
CC       CASP7 and CASP9. {ECO:0000269|PubMed:15200957}.
CC   -!- SUBUNIT: Homodimer. Binds the activated, processed forms of CASP3,
CC       CASP6, CASP7 and CASP9. Interacts with RNF41, DIABLO/SMAC, HTRA2,
CC       KIF23/MKLP1, USP8/UBPY, BIRC5/survivin, MAP2K1/MEK1, RAB8A/RAB8,
CC       RAB11A/RAB11, PLK1, EXOC3/SEC6 and EXOC4/SEC8.
CC       {ECO:0000269|PubMed:14765125, ECO:0000269|PubMed:15200957,
CC       ECO:0000269|PubMed:18329369}.
CC   -!- INTERACTION:
CC       Q96A65:EXOC4; NbExp=3; IntAct=EBI-1765160, EBI-355383;
CC       Q02241:KIF23; NbExp=4; IntAct=EBI-1765160, EBI-306852;
CC       Q02750:MAP2K1; NbExp=2; IntAct=EBI-1765160, EBI-492564;
CC       P53350:PLK1; NbExp=4; IntAct=EBI-1765160, EBI-476768;
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus, trans-Golgi network
CC       membrane {ECO:0000269|PubMed:18329369}. Endosome
CC       {ECO:0000269|PubMed:18329369}. Cytoplasm, cytoskeleton, spindle
CC       pole {ECO:0000269|PubMed:18329369}. Cytoplasm, cytoskeleton,
CC       microtubule organizing center, centrosome
CC       {ECO:0000269|PubMed:18329369}. Midbody, Midbody ring
CC       {ECO:0000269|PubMed:18329369}. Note=Exhibits cell cycle-dependent
CC       localization. Concentrates in a pericentriolar compartment in
CC       interphase, moves partially to spindle poles in metaphase, and
CC       finally localizes to the spindle midzone and the midbody in
CC       telophase and during cytokinesis. On the midbody, localizes to the
CC       midbody ring, also called Flemming body (PubMed:18329369). In
CC       interphase cells, localizes to the trans-Golgi network membrane
CC       and endosomes. During cytokinesis, a fraction moves to the midzone
CC       where it specifically arrives at the midbody ring. After
CC       abscission completion, travels with the midbody remnant into one
CC       daughter cell, and remains bound to it until a new midbody ring is
CC       formed during the next cell division (PubMed:18329369).
CC       {ECO:0000269|PubMed:18329369}.
CC   -!- TISSUE SPECIFICITY: Expressed in brain cancer cells.
CC   -!- DOMAIN: The BIR domain is essential for its antiapoptotic function
CC       and is important for binding to DIABLO/SMAC and CASP9.
CC       {ECO:0000269|PubMed:15200957}.
CC   -!- PTM: Ubiquitinated. Ubiquitination is mediated by the RNF41 E3
CC       ligase and leads to proteasomal degradation, impairing inhibition
CC       of apoptosis. Deubiquitinated by USP8/UBPY.
CC       {ECO:0000269|PubMed:14765125, ECO:0000269|PubMed:18329369}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the ubiquitin-
CC       conjugating enzyme family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA86603.2; Type=Frameshift; Positions=2047; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/BIRC6ID798ch2p22.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC079837; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL133243; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL133245; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL133246; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF265555; AAF75772.1; -; mRNA.
DR   EMBL; AB033115; BAA86603.2; ALT_FRAME; mRNA.
DR   CCDS; CCDS33175.2; -.
DR   RefSeq; NP_057336.3; NM_016252.3.
DR   UniGene; Hs.150107; -.
DR   PDB; 3CEG; X-ray; 2.01 A; A/B=4498-4820.
DR   PDBsum; 3CEG; -.
DR   ProteinModelPortal; Q9NR09; -.
DR   SMR; Q9NR09; -.
DR   BioGrid; 121521; 79.
DR   IntAct; Q9NR09; 20.
DR   STRING; 9606.ENSP00000393596; -.
DR   MEROPS; I32.006; -.
DR   iPTMnet; Q9NR09; -.
DR   PhosphoSitePlus; Q9NR09; -.
DR   BioMuta; BIRC6; -.
DR   DMDM; 313104079; -.
DR   EPD; Q9NR09; -.
DR   MaxQB; Q9NR09; -.
DR   PaxDb; Q9NR09; -.
DR   PeptideAtlas; Q9NR09; -.
DR   PRIDE; Q9NR09; -.
DR   Ensembl; ENST00000421745; ENSP00000393596; ENSG00000115760.
DR   GeneID; 57448; -.
DR   KEGG; hsa:57448; -.
DR   UCSC; uc010ezu.4; human.
DR   CTD; 57448; -.
DR   DisGeNET; 57448; -.
DR   EuPathDB; HostDB:ENSG00000115760.13; -.
DR   GeneCards; BIRC6; -.
DR   H-InvDB; HIX0001957; -.
DR   H-InvDB; HIX0030282; -.
DR   HGNC; HGNC:13516; BIRC6.
DR   HPA; HPA074409; -.
DR   HPA; HPA074738; -.
DR   MIM; 605638; gene.
DR   neXtProt; NX_Q9NR09; -.
DR   PharmGKB; PA25363; -.
DR   eggNOG; KOG0895; Eukaryota.
DR   eggNOG; KOG1101; Eukaryota.
DR   eggNOG; ENOG410XP8C; LUCA.
DR   HOGENOM; HOG000168828; -.
DR   HOVERGEN; HBG050691; -.
DR   InParanoid; Q9NR09; -.
DR   KO; K10586; -.
DR   OrthoDB; EOG091G0T73; -.
DR   PhylomeDB; Q9NR09; -.
DR   TreeFam; TF105357; -.
DR   SignaLink; Q9NR09; -.
DR   SIGNOR; Q9NR09; -.
DR   ChiTaRS; BIRC6; human.
DR   EvolutionaryTrace; Q9NR09; -.
DR   GeneWiki; BIRC6; -.
DR   GenomeRNAi; 57448; -.
DR   PRO; PR:Q9NR09; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000115760; -.
DR   CleanEx; HS_BIRC6; -.
DR   ExpressionAtlas; Q9NR09; baseline and differential.
DR   Genevisible; Q9NR09; HS.
DR   GO; GO:0005768; C:endosome; IDA:UniProtKB.
DR   GO; GO:0090543; C:Flemming body; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005815; C:microtubule organizing center; IDA:UniProtKB.
DR   GO; GO:0030496; C:midbody; IDA:UniProtKB.
DR   GO; GO:0000922; C:spindle pole; IDA:UniProtKB.
DR   GO; GO:0005802; C:trans-Golgi network; IDA:UniProtKB.
DR   GO; GO:0004869; F:cysteine-type endopeptidase inhibitor activity; IMP:UniProtKB.
DR   GO; GO:0061631; F:ubiquitin conjugating enzyme activity; IEA:Ensembl.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0060711; P:labyrinthine layer development; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IMP:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; TAS:UniProtKB.
DR   GO; GO:0042127; P:regulation of cell proliferation; TAS:UniProtKB.
DR   GO; GO:0032465; P:regulation of cytokinesis; IMP:UniProtKB.
DR   GO; GO:0060712; P:spongiotrophoblast layer development; IEA:Ensembl.
DR   CDD; cd00022; BIR; 1.
DR   CDD; cd00195; UBCc; 1.
DR   Gene3D; 3.10.110.10; -; 1.
DR   InterPro; IPR001370; BIR_rpt.
DR   InterPro; IPR022103; BIRC6.
DR   InterPro; IPR000608; UBQ-conjugat_E2.
DR   InterPro; IPR016135; UBQ-conjugating_enzyme/RWD.
DR   Pfam; PF00653; BIR; 1.
DR   Pfam; PF12356; BIRC6; 1.
DR   Pfam; PF00179; UQ_con; 1.
DR   SMART; SM00238; BIR; 1.
DR   SUPFAM; SSF54495; SSF54495; 1.
DR   PROSITE; PS50143; BIR_REPEAT_2; 1.
DR   PROSITE; PS50127; UBIQUITIN_CONJUGAT_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Apoptosis; Cell cycle; Cell division; Complete proteome;
KW   Cytoplasm; Cytoskeleton; Endosome; Golgi apparatus; Membrane; Mitosis;
KW   Phosphoprotein; Protease inhibitor; Reference proteome;
KW   Thiol protease inhibitor; Transferase; Ubl conjugation;
KW   Ubl conjugation pathway.
FT   CHAIN         1   4857       Baculoviral IAP repeat-containing protein
FT                                6.
FT                                /FTId=PRO_0000122361.
FT   REPEAT      284    358       BIR.
FT   REGION     4576   4704       Ubiquitin-conjugating.
FT   COMPBIAS     30     36       Poly-Ala.
FT   COMPBIAS   1660   1668       Poly-Ala.
FT   ACT_SITE   4625   4625       Glycyl thioester intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00388}.
FT   MOD_RES     473    473       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88738}.
FT   MOD_RES     480    480       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     482    482       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88738}.
FT   MOD_RES     581    581       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     590    590       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1710   1710       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    2222   2222       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2955   2955       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    3931   3931       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    4023   4023       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CONFLICT   1332   1332       V -> L (in Ref. 2; AAF75772).
FT                                {ECO:0000305}.
FT   CONFLICT   2319   2319       L -> F (in Ref. 3; BAA86603).
FT                                {ECO:0000305}.
FT   CONFLICT   2674   2674       T -> S (in Ref. 2; AAF75772).
FT                                {ECO:0000305}.
FT   HELIX      4524   4533       {ECO:0000244|PDB:3CEG}.
FT   STRAND     4536   4540       {ECO:0000244|PDB:3CEG}.
FT   STRAND     4543   4545       {ECO:0000244|PDB:3CEG}.
FT   STRAND     4551   4555       {ECO:0000244|PDB:3CEG}.
FT   HELIX      4560   4564       {ECO:0000244|PDB:3CEG}.
FT   HELIX      4572   4588       {ECO:0000244|PDB:3CEG}.
FT   STRAND     4597   4604       {ECO:0000244|PDB:3CEG}.
FT   STRAND     4608   4615       {ECO:0000244|PDB:3CEG}.
FT   STRAND     4625   4631       {ECO:0000244|PDB:3CEG}.
FT   TURN       4634   4638       {ECO:0000244|PDB:3CEG}.
FT   STRAND     4642   4645       {ECO:0000244|PDB:3CEG}.
FT   TURN       4649   4652       {ECO:0000244|PDB:3CEG}.
FT   HELIX      4668   4670       {ECO:0000244|PDB:3CEG}.
FT   HELIX      4677   4679       {ECO:0000244|PDB:3CEG}.
FT   TURN       4683   4685       {ECO:0000244|PDB:3CEG}.
FT   HELIX      4688   4698       {ECO:0000244|PDB:3CEG}.
FT   HELIX      4704   4707       {ECO:0000244|PDB:3CEG}.
FT   HELIX      4711   4714       {ECO:0000244|PDB:3CEG}.
FT   HELIX      4718   4738       {ECO:0000244|PDB:3CEG}.
FT   HELIX      4741   4745       {ECO:0000244|PDB:3CEG}.
FT   TURN       4749   4751       {ECO:0000244|PDB:3CEG}.
FT   HELIX      4752   4777       {ECO:0000244|PDB:3CEG}.
FT   HELIX      4788   4810       {ECO:0000244|PDB:3CEG}.
SQ   SEQUENCE   4857 AA;  530255 MW;  0F5939F9C40F4270 CRC64;
     MVTGGGAAPP GTVTEPLPSV IVLSAGRKMA AAAAAASGPG CSSAAGAGAA GVSEWLVLRD
     GCMHCDADGL HSLSYHPALN AILAVTSRGT IKVIDGTSGA TLQASALSAK PGGQVKCQYI
     SAVDKVIFVD DYAVGCRKDL NGILLLDTAL QTPVSKQDDV VQLELPVTEA QQLLSACLEK
     VDISSTEGYD LFITQLKDGL KNTSHETAAN HKVAKWATVT FHLPHHVLKS IASAIVNELK
     KINQNVAALP VASSVMDRLS YLLPSARPEL GVGPGRSVDR SLMYSEANRR ETFTSWPHVG
     YRWAQPDPMA QAGFYHQPAS SGDDRAMCFT CSVCLVCWEP TDEPWSEHER HSPNCPFVKG
     EHTQNVPLSV TLATSPAQFP CTDGTDRISC FGSGSCPHFL AAATKRGKIC IWDVSKLMKV
     HLKFEINAYD PAIVQQLILS GDPSSGVDSR RPTLAWLEDS SSCSDIPKLE GDSDDLLEDS
     DSEEHSRSDS VTGHTSQKEA MEVSLDITAL SILQQPEKLQ WEIVANVLED TVKDLEELGA
     NPCLTNSKSE KTKEKHQEQH NIPFPCLLAG GLLTYKSPAT SPISSNSHRS LDGLSRTQGE
     SISEQGSTDN ESCTNSELNS PLVRRTLPVL LLYSIKESDE KAGKIFSQMN NIMSKSLHDD
     GFTVPQIIEM ELDSQEQLLL QDPPVTYIQQ FADAAANLTS PDSEKWNSVF PKPGTLVQCL
     RLPKFAEEEN LCIDSITPCA DGIHLLVGLR TCPVESLSAI NQVEALNNLN KLNSALCNRR
     KGELESNLAV VNGANISVIQ HESPADVQTP LIIQPEQRNV SGGYLVLYKM NYATRIVTLE
     EEPIKIQHIK DPQDTITSLI LLPPDILDNR EDDCEEPIED MQLTSKNGFE REKTSDISTL
     GHLVITTQGG YVKILDLSNF EILAKVEPPK KEGTEEQDTF VSVIYCSGTD RLCACTKGGE
     LHFLQIGGTC DDIDEADILV DGSLSKGIEP SSEGSKPLSN PSSPGISGVD LLVDQPFTLE
     ILTSLVELTR FETLTPRFSA TVPPCWVEVQ QEQQQRRHPQ HLHQQHHGDA AQHTRTWKLQ
     TDSNSWDEHV FELVLPKACM VGHVDFKFVL NSNITNIPQI QVTLLKNKAP GLGKVNALNI
     EVEQNGKPSL VDLNEEMQHM DVEESQCLRL CPFLEDHKED ILCGPVWLAS GLDLSGHAGM
     LTLTSPKLVK GMAGGKYRSF LIHVKAVNER GTEEICNGGM RPVVRLPSLK HQSNKGYSLA
     SLLAKVAAGK EKSSNVKNEN TSGTRKSENL RGCDLLQEVS VTIRRFKKTS ISKERVQRCA
     MLQFSEFHEK LVNTLCRKTD DGQITEHAQS LVLDTLCWLA GVHSNGPGSS KEGNENLLSK
     TRKFLSDIVR VCFFEAGRSI AHKCARFLAL CISNGKCDPC QPAFGPVLLK ALLDNMSFLP
     AATTGGSVYW YFVLLNYVKD EDLAGCSTAC ASLLTAVSRQ LQDRLTPMEA LLQTRYGLYS
     SPFDPVLFDL EMSGSSCKNV YNSSIGVQSD EIDLSDVLSG NGKVSSCTAA EGSFTSLTGL
     LEVEPLHFTC VSTSDGTRIE RDDAMSSFGV TPAVGGLSSG TVGEASTALS SAAQVALQSL
     SHAMASAEQQ LQVLQEKQQQ LLKLQQQKAK LEAKLHQTTA AAAAAASAVG PVHNSVPSNP
     VAAPGFFIHP SDVIPPTPKT TPLFMTPPLT PPNEAVSVVI NAELAQLFPG SVIDPPAVNL
     AAHNKNSNKS RMNPLGSGLA LAISHASHFL QPPPHQSIII ERMHSGARRF VTLDFGRPIL
     LTDVLIPTCG DLASLSIDIW TLGEEVDGRR LVVATDISTH SLILHDLIPP PVCRFMKITV
     IGRYGSTNAR AKIPLGFYYG HTYILPWESE LKLMHDPLKG EGESANQPEI DQHLAMMVAL
     QEDIQCRYNL ACHRLETLLQ SIDLPPLNSA NNAQYFLRKP DKAVEEDSRV FSAYQDCIQL
     QLQLNLAHNA VQRLKVALGA SRKMLSETSN PEDLIQTSST EQLRTIIRYL LDTLLSLLHA
     SNGHSVPAVL QSTFHAQACE ELFKHLCISG TPKIRLHTGL LLVQLCGGER WWGQFLSNVL
     QELYNSEQLL IFPQDRVFML LSCIGQRSLS NSGVLESLLN LLDNLLSPLQ PQLPMHRRTE
     GVLDIPMISW VVMLVSRLLD YVATVEDEAA AAKKPLNGNQ WSFINNNLHT QSLNRSSKGS
     SSLDRLYSRK IRKQLVHHKQ QLNLLKAKQK ALVEQMEKEK IQSNKGSSYK LLVEQAKLKQ
     ATSKHFKDLI RLRRTAEWSR SNLDTEVTTA KESPEIEPLP FTLAHERCIS VVQKLVLFLL
     SMDFTCHADL LLFVCKVLAR IANATRPTIH LCEIVNEPQL ERLLLLLVGT DFNRGDISWG
     GAWAQYSLTC MLQDILAGEL LAPVAAEAME EGTVGDDVGA TAGDSDDSLQ QSSVQLLETI
     DEPLTHDITG APPLSSLEKD KEIDLELLQD LMEVDIDPLD IDLEKDPLAA KVFKPISSTW
     YDYWGADYGT YNYNPYIGGL GIPVAKPPAN TEKNGSQTVS VSVSQALDAR LEVGLEQQAE
     LMLKMMSTLE ADSILQALTN TSPTLSQSPT GTDDSLLGGL QAANQTSQLI IQLSSVPMLN
     VCFNKLFSML QVHHVQLESL LQLWLTLSLN SSSTGNKENG ADIFLYNANR IPVISLNQAS
     ITSFLTVLAW YPNTLLRTWC LVLHSLTLMT NMQLNSGSSS AIGTQESTAH LLVSDPNLIH
     VLVKFLSGTS PHGTNQHSPQ VGPTATQAMQ EFLTRLQVHL SSTCPQIFSE FLLKLIHILS
     TERGAFQTGQ GPLDAQVKLL EFTLEQNFEV VSVSTISAVI ESVTFLVHHY ITCSDKVMSR
     SGSDSSVGAR ACFGGLFANL IRPGDAKAVC GEMTRDQLMF DLLKLVNILV QLPLSGNREY
     SARVSVTTNT TDSVSDEEKV SGGKDGNGSS TSVQGSPAYV ADLVLANQQI MSQILSALGL
     CNSSAMAMII GASGLHLTKH ENFHGGLDAI SVGDGLFTIL TTLSKKASTV HMMLQPILTY
     MACGYMGRQG SLATCQLSEP LLWFILRVLD TSDALKAFHD MGGVQLICNN MVTSTRAIVN
     TARSMVSTIM KFLDSGPNKA VDSTLKTRIL ASEPDNAEGI HNFAPLGTIT SSSPTAQPAE
     VLLQATPPHR RARSAAWSYI FLPEEAWCDL TIHLPAAVLL KEIHIQPHLA SLATCPSSVS
     VEVSADGVNM LPLSTPVVTS GLTYIKIQLV KAEVASAVCL RLHRPRDAST LGLSQIKLLG
     LTAFGTTSSA TVNNPFLPSE DQVSKTSIGW LRLLHHCLTH ISDLEGMMAS AAAPTANLLQ
     TCAALLMSPY CGMHSPNIEV VLVKIGLQST RIGLKLIDIL LRNCAASGSD PTDLNSPLLF
     GRLNGLSSDS TIDILYQLGT TQDPGTKDRI QALLKWVSDS ARVAAMKRSG RMNYMCPNSS
     TVEYGLLMPS PSHLHCVAAI LWHSYELLVE YDLPALLDQE LFELLFNWSM SLPCNMVLKK
     AVDSLLCSMC HVHPNYFSLL MGWMGITPPP VQCHHRLSMT DDSKKQDLSS SLTDDSKNAQ
     APLALTESHL ATLASSSQSP EAIKQLLDSG LPSLLVRSLA SFCFSHISSS ESIAQSIDIS
     QDKLRRHHVP QQCNKMPITA DLVAPILRFL TEVGNSHIMK DWLGGSEVNP LWTALLFLLC
     HSGSTSGSHN LGAQQTSARS ASLSSAATTG LTTQQRTAIE NATVAFFLQC ISCHPNNQKL
     MAQVLCELFQ TSPQRGNLPT SGNISGFIRR LFLQLMLEDE KVTMFLQSPC PLYKGRINAT
     SHVIQHPMYG AGHKFRTLHL PVSTTLSDVL DRVSDTPSIT AKLISEQKDD KEKKNHEEKE
     KVKAENGFQD NYSVVVASGL KSQSKRAVSA TPPRPPSRRG RTIPDKIGST SGAEAANKII
     TVPVFHLFHK LLAGQPLPAE MTLAQLLTLL YDRKLPQGYR SIDLTVKLGS RVITDPSLSK
     TDSYKRLHPE KDHGDLLASC PEDEALTPGD ECMDGILDES LLETCPIQSP LQVFAGMGGL
     ALIAERLPML YPEVIQQVSA PVVTSTTQEK PKDSDQFEWV TIEQSGELVY EAPETVAAEP
     PPIKSAVQTM SPIPAHSLAA FGLFLRLPGY AEVLLKERKH AQCLLRLVLG VTDDGEGSHI
     LQSPSANVLP TLPFHVLRSL FSTTPLTTDD GVLLRRMALE IGALHLILVC LSALSHHSPR
     VPNSSVNQTE PQVSSSHNPT STEEQQLYWA KGTGFGTGST ASGWDVEQAL TKQRLEEEHV
     TCLLQVLASY INPVSSAVNG EAQSSHETRG QNSNALPSVL LELLSQSCLI PAMSSYLRND
     SVLDMARHVP LYRALLELLR AIASCAAMVP LLLPLSTENG EEEEEQSECQ TSVGTLLAKM
     KTCVDTYTNR LRSKRENVKT GVKPDASDQE PEGLTLLVPD IQKTAEIVYA ATTSLRQANQ
     EKKLGEYSKK AAMKPKPLSV LKSLEEKYVA VMKKLQFDTF EMVSEDEDGK LGFKVNYHYM
     SQVKNANDAN SAARARRLAQ EAVTLSTSLP LSSSSSVFVR CDEERLDIMK VLITGPADTP
     YANGCFEFDV YFPQDYPSSP PLVNLETTGG HSVRFNPNLY NDGKVCLSIL NTWHGRPEEK
     WNPQTSSFLQ VLVSVQSLIL VAEPYFNEPG YERSRGTPSG TQSSREYDGN IRQATVKWAM
     LEQIRNPSPC FKEVIHKHFY LKRVEIMAQC EEWIADIQQY SSDKRVGRTM SHHAAALKRH
     TAQLREELLK LPCPEGLDPD TDDAPEVCRA TTGAEETLMH DQVKPSSSKE LPSDFQL
//
ID   A0A024RBL0_HUMAN        Unreviewed;       352 AA.
AC   A0A024RBL0;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 26.
DE   RecName: Full=Carbohydrate sulfotransferase {ECO:0000256|RuleBase:RU364020};
DE            EC=2.8.2.- {ECO:0000256|RuleBase:RU364020};
GN   Name=CHST11 {ECO:0000313|EMBL:EAW97749.1};
GN   ORFNames=hCG_2015274 {ECO:0000313|EMBL:EAW97749.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW97749.1};
RN   [1] {ECO:0000313|EMBL:EAW97749.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW97749.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane
CC       {ECO:0000256|RuleBase:RU364020}; Single-pass type II membrane
CC       protein {ECO:0000256|RuleBase:RU364020}.
CC   -!- SIMILARITY: Belongs to the sulfotransferase 2 family.
CC       {ECO:0000256|RuleBase:RU364020}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471054; EAW97749.1; -; Genomic_DNA.
DR   RefSeq; NP_060883.1; NM_018413.5.
DR   UniGene; Hs.17569; -.
DR   ProteinModelPortal; A0A024RBL0; -.
DR   PRIDE; A0A024RBL0; -.
DR   GeneID; 50515; -.
DR   KEGG; hsa:50515; -.
DR   CTD; 50515; -.
DR   EuPathDB; HostDB:ENSG00000171310.10; -.
DR   eggNOG; KOG4651; Eukaryota.
DR   eggNOG; ENOG4111GJR; LUCA.
DR   KO; K01017; -.
DR   OMA; PLNEHWQ; -.
DR   OrthoDB; EOG091G0FZO; -.
DR   PhylomeDB; A0A024RBL0; -.
DR   ChiTaRS; CHST11; human.
DR   GenomeRNAi; 50515; -.
DR   Bgee; ENSG00000171310; -.
DR   ExpressionAtlas; A0A024RBL0; baseline and differential.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:InterPro.
DR   GO; GO:0050659; F:N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity; IEA:Ensembl.
DR   GO; GO:0016051; P:carbohydrate biosynthetic process; IEA:InterPro.
DR   GO; GO:0002063; P:chondrocyte development; IEA:Ensembl.
DR   GO; GO:0030206; P:chondroitin sulfate biosynthetic process; IEA:Ensembl.
DR   GO; GO:0048589; P:developmental growth; IEA:Ensembl.
DR   GO; GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl.
DR   GO; GO:0048703; P:embryonic viscerocranium morphogenesis; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0033037; P:polysaccharide localization; IEA:Ensembl.
DR   GO; GO:0036342; P:post-anal tail morphogenesis; IEA:Ensembl.
DR   GO; GO:0009791; P:post-embryonic development; IEA:Ensembl.
DR   GO; GO:0042127; P:regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0007585; P:respiratory gaseous exchange; IEA:Ensembl.
DR   InterPro; IPR018011; Carb_sulfotrans_8-10.
DR   InterPro; IPR005331; Sulfotransferase.
DR   PANTHER; PTHR12137; PTHR12137; 1.
DR   Pfam; PF03567; Sulfotransfer_2; 1.
PE   3: Inferred from homology;
KW   Carbohydrate metabolism {ECO:0000256|RuleBase:RU364020};
KW   Glycoprotein {ECO:0000256|RuleBase:RU364020};
KW   Golgi apparatus {ECO:0000256|RuleBase:RU364020};
KW   Membrane {ECO:0000256|RuleBase:RU364020};
KW   Signal-anchor {ECO:0000256|RuleBase:RU364020};
KW   Transferase {ECO:0000256|RuleBase:RU364020,
KW   ECO:0000313|EMBL:EAW97749.1};
KW   Transmembrane {ECO:0000256|RuleBase:RU364020}.
SQ   SEQUENCE   352 AA;  41555 MW;  55DF1D29D6703307 CRC64;
     MKPALLEVMR MNRICRMVLA TCLGSFILVI FYFQSMLHPV MRRNPFGVDI CCRKGSRSPL
     QELYNPIQLE LSNTAVLHQM RRDQVTDTCR ANSATSRKRR VLTPNDLKHL VVDEDHELIY
     CYVPKVACTN WKRLMMVLTG RGKYSDPMEI PANEAHVSAN LKTLNQYSIP EINHRLKSYM
     KFLFVREPFE RLVSAYRNKF TQKYNISFHK RYGTKIIKRQ RKNATQEALR KGDDVKFEEF
     VAYLIDPHTQ REEPFNEHWQ TVYSLCHPCH IHYDLVGKYE TLEEDSNYVL QLAGVGSYLK
     FPTYAKSTRT TDEMTTEFFQ NISSEHQTQL YEVYKLDFLM FNYSVPSYLK LE
//
ID   CHSTB_HUMAN             Reviewed;         352 AA.
AC   Q9NPF2; A8K4F8; Q9NXY6; Q9NY36;
DT   15-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   28-MAR-2018, entry version 133.
DE   RecName: Full=Carbohydrate sulfotransferase 11;
DE            EC=2.8.2.5;
DE   AltName: Full=Chondroitin 4-O-sulfotransferase 1;
DE   AltName: Full=Chondroitin 4-sulfotransferase 1;
DE            Short=C4S-1;
DE            Short=C4ST-1;
DE            Short=C4ST1;
GN   Name=CHST11;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), ENZYME ACTIVITY, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Fetal brain;
RX   PubMed=11056388; DOI=10.1093/oxfordjournals.jbchem.a022813;
RA   Okuda T., Mita S., Yamauchi S., Matsubara T., Yagi F., Yamamori D.,
RA   Fukuta M., Kuroiwa A., Matsuda Y., Habuchi O.;
RT   "Molecular cloning, expression, and chromosomal mapping of human
RT   chondroitin 4-sulfotransferase, whose expression pattern in human
RT   tissues is different from that of chondroitin 6-sulfotransferase.";
RL   J. Biochem. 128:763-770(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), ENZYME ACTIVITY, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=10781601; DOI=10.1074/jbc.M002443200;
RA   Hiraoka N., Nakagawa H., Ong E., Akama O.T., Fukuda N.M., Fukuda M.;
RT   "Molecular cloning and expression of two distinct human chondroitin 4-
RT   O-sulfotransferases that belong to the HNK-1 sulfotransferase gene
RT   family.";
RL   J. Biol. Chem. 275:20188-20196(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RA   Xia G., Evers M.R., Schachner M.;
RT   "Cloning and expression of a human chondroitin-4-sulfotransferase
RT   similar to members of the HNK-1 sulfotransferase family.";
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   SUBSTRATE SPECIFICITY.
RX   PubMed=12847091; DOI=10.1074/jbc.M306044200;
RA   Mikami T., Mizumoto S., Kago N., Kitagawa H., Sugahara K.;
RT   "Specificities of three distinct human chondroitin/dermatan N-
RT   acetylgalactosamine 4-O-sulfotransferases demonstrated using partially
RT   desulfated dermatan sulfate as an acceptor. Implication of
RT   differential roles in dermatan sulfate biosynthesis.";
RL   J. Biol. Chem. 278:36115-36127(2003).
RN   [8]
RP   DISEASE, AND CHROMOSOMAL TRANSLOCATION WITH IGH.
RX   PubMed=15273723; DOI=10.1038/sj.onc.1207934;
RA   Schmidt H.H., Dyomin V.G., Palanisamy N., Itoyama T., Nanjangud G.,
RA   Pirc-Danoewinata H., Haas O.A., Chaganti R.S.K.;
RT   "Deregulation of the carbohydrate (chondroitin 4) sulfotransferase 11
RT   (CHST11) gene in a B-cell chronic lymphocytic leukemia with a
RT   t(12;14)(q23;q32).";
RL   Oncogene 23:6991-6996(2004).
RN   [9]
RP   BIOPHYSICOCHEMICAL PROPERTIES, GLYCOSYLATION, AND MUTAGENESIS OF
RP   LYS-125; ASN-205; ASN-223 AND ASN-342.
RX   PubMed=15628971; DOI=10.1042/BJ20041573;
RA   Yusa A., Kitajima K., Habuchi O.;
RT   "N-linked oligosaccharides are required to produce and stabilize the
RT   active form of chondroitin 4-sulphotransferase-1.";
RL   Biochem. J. 388:115-121(2005).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
CC   -!- FUNCTION: Catalyzes the transfer of sulfate to position 4 of the
CC       N-acetylgalactosamine (GalNAc) residue of chondroitin. Chondroitin
CC       sulfate constitutes the predominant proteoglycan present in
CC       cartilage and is distributed on the surfaces of many cells and
CC       extracellular matrices. Can also sulfate Gal residues in
CC       desulfated dermatan sulfate. Preferentially sulfates in
CC       GlcA->GalNAc unit than in IdoA->GalNAc unit. Does not form 4, 6-
CC       di-O-sulfated GalNAc when chondroitin sulfate C is used as an
CC       acceptor.
CC   -!- CATALYTIC ACTIVITY: 3'-phosphoadenylyl sulfate + chondroitin =
CC       adenosine 3',5'-bisphosphate + chondroitin 4'-sulfate.
CC       {ECO:0000269|PubMed:10781601, ECO:0000269|PubMed:11056388}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.5 uM for PAPS {ECO:0000269|PubMed:15628971};
CC         KM=2.1 mM for chondroitin {ECO:0000269|PubMed:15628971};
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250};
CC       Single-pass type II membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NPF2-1; Sequence=Displayed;
CC       Name=2; Synonyms=C4S-1A;
CC         IsoId=Q9NPF2-2; Sequence=VSP_012992;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Highly expressed in spleen,
CC       thymus, bone marrow, peripheral blood leukocytes, lymph node,
CC       heart, brain, lung and placenta. {ECO:0000269|PubMed:10781601,
CC       ECO:0000269|PubMed:11056388}.
CC   -!- PTM: N-glycosylated; required for activity and stability.
CC       {ECO:0000269|PubMed:15628971}.
CC   -!- DISEASE: Note=A chromosomal aberration involving CHST11 is found
CC       in B-cell chronic lymphocytic leukemias. Translocation
CC       t(12;14)(q23;q32) with IgH. {ECO:0000269|PubMed:15273723}.
CC   -!- SIMILARITY: Belongs to the sulfotransferase 2 family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB042326; BAA95485.1; -; mRNA.
DR   EMBL; AF239820; AAF81691.1; -; mRNA.
DR   EMBL; AJ269537; CAB87380.1; -; mRNA.
DR   EMBL; AJ289134; CAB92134.1; -; mRNA.
DR   EMBL; AK290923; BAF83612.1; -; mRNA.
DR   EMBL; CH471054; EAW97748.1; -; Genomic_DNA.
DR   EMBL; BC013315; AAH13315.1; -; mRNA.
DR   CCDS; CCDS55878.1; -. [Q9NPF2-2]
DR   CCDS; CCDS9099.1; -. [Q9NPF2-1]
DR   PIR; JC7525; JC7525.
DR   RefSeq; NP_001167453.1; NM_001173982.1. [Q9NPF2-2]
DR   RefSeq; NP_060883.1; NM_018413.5. [Q9NPF2-1]
DR   UniGene; Hs.17569; -.
DR   ProteinModelPortal; Q9NPF2; -.
DR   BioGrid; 119084; 5.
DR   STRING; 9606.ENSP00000305725; -.
DR   iPTMnet; Q9NPF2; -.
DR   PhosphoSitePlus; Q9NPF2; -.
DR   SwissPalm; Q9NPF2; -.
DR   BioMuta; CHST11; -.
DR   DMDM; 61212137; -.
DR   EPD; Q9NPF2; -.
DR   MaxQB; Q9NPF2; -.
DR   PaxDb; Q9NPF2; -.
DR   PeptideAtlas; Q9NPF2; -.
DR   PRIDE; Q9NPF2; -.
DR   DNASU; 50515; -.
DR   Ensembl; ENST00000303694; ENSP00000305725; ENSG00000171310. [Q9NPF2-1]
DR   Ensembl; ENST00000549260; ENSP00000450004; ENSG00000171310. [Q9NPF2-2]
DR   GeneID; 50515; -.
DR   KEGG; hsa:50515; -.
DR   UCSC; uc001tky.4; human. [Q9NPF2-1]
DR   CTD; 50515; -.
DR   DisGeNET; 50515; -.
DR   EuPathDB; HostDB:ENSG00000171310.10; -.
DR   GeneCards; CHST11; -.
DR   HGNC; HGNC:17422; CHST11.
DR   HPA; HPA052828; -.
DR   MIM; 610128; gene.
DR   neXtProt; NX_Q9NPF2; -.
DR   OpenTargets; ENSG00000171310; -.
DR   PharmGKB; PA134875681; -.
DR   eggNOG; KOG4651; Eukaryota.
DR   eggNOG; ENOG4111GJR; LUCA.
DR   GeneTree; ENSGT00760000119214; -.
DR   HOGENOM; HOG000231801; -.
DR   HOVERGEN; HBG050952; -.
DR   InParanoid; Q9NPF2; -.
DR   KO; K01017; -.
DR   OMA; PLNEHWQ; -.
DR   OrthoDB; EOG091G0FZO; -.
DR   PhylomeDB; Q9NPF2; -.
DR   TreeFam; TF325581; -.
DR   BioCyc; MetaCyc:HS10284-MONOMER; -.
DR   BRENDA; 2.8.2.5; 2681.
DR   Reactome; R-HSA-2022870; Chondroitin sulfate biosynthesis.
DR   ChiTaRS; CHST11; human.
DR   GeneWiki; CHST11; -.
DR   GenomeRNAi; 50515; -.
DR   PRO; PR:Q9NPF2; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000171310; -.
DR   CleanEx; HS_CHST11; -.
DR   ExpressionAtlas; Q9NPF2; baseline and differential.
DR   Genevisible; Q9NPF2; HS.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0047756; F:chondroitin 4-sulfotransferase activity; IDA:UniProtKB.
DR   GO; GO:0001537; F:N-acetylgalactosamine 4-O-sulfotransferase activity; IDA:UniProtKB.
DR   GO; GO:0050659; F:N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity; IEA:Ensembl.
DR   GO; GO:0016051; P:carbohydrate biosynthetic process; IEA:InterPro.
DR   GO; GO:0002063; P:chondrocyte development; IEA:Ensembl.
DR   GO; GO:0030206; P:chondroitin sulfate biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0048589; P:developmental growth; IEA:Ensembl.
DR   GO; GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl.
DR   GO; GO:0048703; P:embryonic viscerocranium morphogenesis; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0033037; P:polysaccharide localization; IEA:Ensembl.
DR   GO; GO:0036342; P:post-anal tail morphogenesis; IEA:Ensembl.
DR   GO; GO:0009791; P:post-embryonic development; IEA:Ensembl.
DR   GO; GO:0042127; P:regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0007585; P:respiratory gaseous exchange; IEA:Ensembl.
DR   InterPro; IPR018011; Carb_sulfotrans_8-10.
DR   InterPro; IPR005331; Sulfotransferase.
DR   PANTHER; PTHR12137; PTHR12137; 1.
DR   Pfam; PF03567; Sulfotransfer_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Carbohydrate metabolism;
KW   Chromosomal rearrangement; Complete proteome; Glycoprotein;
KW   Golgi apparatus; Membrane; Reference proteome; Signal-anchor;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    352       Carbohydrate sulfotransferase 11.
FT                                /FTId=PRO_0000189664.
FT   TOPO_DOM      1     16       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     17     37       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     38    352       Lumenal. {ECO:0000255}.
FT   NP_BIND     124    130       PAPS. {ECO:0000250}.
FT   NP_BIND     186    194       PAPS. {ECO:0000250}.
FT   CARBOHYD    205    205       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    223    223       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    321    321       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    342    342       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000305|PubMed:15628971}.
FT   VAR_SEQ      35     40       SMLHPV -> I (in isoform 2).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_012992.
FT   MUTAGEN     125    125       K->Q: Abolishes enzyme activity but does
FT                                not affect stability of the protein.
FT                                {ECO:0000269|PubMed:15628971}.
FT   MUTAGEN     205    205       N->S: Induces a weak decrease in enzyme
FT                                activity but has no effect on stability
FT                                of the protein. Unstable protein; when
FT                                associated with S-223 and S-321.
FT                                {ECO:0000269|PubMed:15628971}.
FT   MUTAGEN     223    223       N->S: Induces a weak decrease in enzyme
FT                                activity but has no effect on stability
FT                                of the protein. Unstable protein; when
FT                                associated with S-205 and S-321.
FT                                {ECO:0000269|PubMed:15628971}.
FT   MUTAGEN     321    321       N->S: Induces a strong decrease in enzyme
FT                                activity but has no effect on stability
FT                                of the protein. Unstable protein; when
FT                                associated with S-205 and S-223.
FT   MUTAGEN     342    342       N->S: Induces a strong decrease in enzyme
FT                                activity has no effect on stability of
FT                                the protein.
FT                                {ECO:0000269|PubMed:15628971}.
FT   CONFLICT    289    289       V -> F (in Ref. 3; CAB87380).
FT                                {ECO:0000305}.
SQ   SEQUENCE   352 AA;  41555 MW;  55DF1D29D6703307 CRC64;
     MKPALLEVMR MNRICRMVLA TCLGSFILVI FYFQSMLHPV MRRNPFGVDI CCRKGSRSPL
     QELYNPIQLE LSNTAVLHQM RRDQVTDTCR ANSATSRKRR VLTPNDLKHL VVDEDHELIY
     CYVPKVACTN WKRLMMVLTG RGKYSDPMEI PANEAHVSAN LKTLNQYSIP EINHRLKSYM
     KFLFVREPFE RLVSAYRNKF TQKYNISFHK RYGTKIIKRQ RKNATQEALR KGDDVKFEEF
     VAYLIDPHTQ REEPFNEHWQ TVYSLCHPCH IHYDLVGKYE TLEEDSNYVL QLAGVGSYLK
     FPTYAKSTRT TDEMTTEFFQ NISSEHQTQL YEVYKLDFLM FNYSVPSYLK LE
//
ID   FOXR1_HUMAN             Reviewed;         292 AA.
AC   Q6PIV2; B0YJ15; Q08AS8; Q86UT9; Q8IXX2;
DT   17-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   28-MAR-2018, entry version 126.
DE   RecName: Full=Forkhead box protein R1;
DE   AltName: Full=Forkhead box protein N5;
GN   Name=FOXR1; Synonyms=FOXN5; ORFNames=DLNB13;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Kubo T., Arai Y., Ohira M., Gamou T., Maeno G., Sakiyama T.,
RA   Toyoda A., Hattori M., Sakaki Y., Nakagawara A., Ohki M.;
RT   "Identification of a 500-kb region of common allelic loss in
RT   chromosome 11q23 in non-MYCN amplified type of neuroblastoma.";
RL   Submitted (OCT-2002) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- INTERACTION:
CC       Q8N9N5:BANP; NbExp=3; IntAct=EBI-10253815, EBI-744695;
CC       Q96LK0:CEP19; NbExp=4; IntAct=EBI-10253815, EBI-741885;
CC       Q53SE7:FLJ13057; NbExp=3; IntAct=EBI-10253815, EBI-10172181;
CC       P50222:MEOX2; NbExp=3; IntAct=EBI-10253815, EBI-748397;
CC       Q96CD2:PPCDC; NbExp=5; IntAct=EBI-10253815, EBI-724333;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q6PIV2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6PIV2-2; Sequence=VSP_056600, VSP_056601;
CC         Note=No experimental confirmation available.;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB094092; BAC76046.1; -; mRNA.
DR   EMBL; EF444979; ACA05993.1; -; Genomic_DNA.
DR   EMBL; AP003392; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP004609; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC028191; AAH28191.2; -; mRNA.
DR   EMBL; BC038969; AAH38969.2; -; mRNA.
DR   EMBL; BC125040; AAI25041.1; -; mRNA.
DR   CCDS; CCDS31688.1; -. [Q6PIV2-1]
DR   RefSeq; NP_859072.1; NM_181721.2. [Q6PIV2-1]
DR   UniGene; Hs.116679; -.
DR   ProteinModelPortal; Q6PIV2; -.
DR   SMR; Q6PIV2; -.
DR   BioGrid; 129476; 41.
DR   IntAct; Q6PIV2; 38.
DR   MINT; Q6PIV2; -.
DR   STRING; 9606.ENSP00000314806; -.
DR   iPTMnet; Q6PIV2; -.
DR   PhosphoSitePlus; Q6PIV2; -.
DR   BioMuta; FOXR1; -.
DR   DMDM; 116247781; -.
DR   PaxDb; Q6PIV2; -.
DR   PeptideAtlas; Q6PIV2; -.
DR   PRIDE; Q6PIV2; -.
DR   Ensembl; ENST00000317011; ENSP00000314806; ENSG00000176302. [Q6PIV2-1]
DR   Ensembl; ENST00000531539; ENSP00000433394; ENSG00000176302. [Q6PIV2-2]
DR   Ensembl; ENST00000626640; ENSP00000487495; ENSG00000281277. [Q6PIV2-1]
DR   Ensembl; ENST00000634955; ENSP00000489241; ENSG00000281277. [Q6PIV2-2]
DR   GeneID; 283150; -.
DR   KEGG; hsa:283150; -.
DR   UCSC; uc001pui.4; human. [Q6PIV2-1]
DR   CTD; 283150; -.
DR   DisGeNET; 283150; -.
DR   EuPathDB; HostDB:ENSG00000176302.12; -.
DR   GeneCards; FOXR1; -.
DR   HGNC; HGNC:29980; FOXR1.
DR   MIM; 615755; gene.
DR   neXtProt; NX_Q6PIV2; -.
DR   OpenTargets; ENSG00000176302; -.
DR   PharmGKB; PA134959382; -.
DR   eggNOG; KOG2294; Eukaryota.
DR   eggNOG; COG5025; LUCA.
DR   GeneTree; ENSGT00910000144055; -.
DR   HOGENOM; HOG000213797; -.
DR   HOVERGEN; HBG080262; -.
DR   InParanoid; Q6PIV2; -.
DR   OMA; DFEPNLW; -.
DR   OrthoDB; EOG091G0G6D; -.
DR   PhylomeDB; Q6PIV2; -.
DR   TreeFam; TF329867; -.
DR   ChiTaRS; FOXR1; human.
DR   GenomeRNAi; 283150; -.
DR   PRO; PR:Q6PIV2; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000176302; -.
DR   CleanEx; HS_FOXR1; -.
DR   ExpressionAtlas; Q6PIV2; baseline and differential.
DR   Genevisible; Q6PIV2; HS.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; ISM:NTNU_SB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; IBA:GO_Central.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR001766; Fork_head_dom.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   Pfam; PF00250; Forkhead; 1.
DR   PRINTS; PR00053; FORKHEAD.
DR   SMART; SM00339; FH; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   PROSITE; PS50039; FORK_HEAD_3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; DNA-binding; Nucleus;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    292       Forkhead box protein R1.
FT                                /FTId=PRO_0000253778.
FT   DNA_BIND    173    272       Fork-head. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00089}.
FT   VAR_SEQ     129    205       LTEEEEAEDQEDSSSMALPSPHKRAPLQSRRLRQASSQAGR
FT                                LWSRPPLNYFHLIALALRNSSPCGLNVQQIYSFTRK -> G
FT                                PPPESEASASQQPGGEALVPAPSQLLPPNCPGIKKQFPLWP
FT                                QRATDLQFHSELLGLILLCSCCGPSPGPSEGGRVQ (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_056600.
FT   VAR_SEQ     206    291       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_056601.
SQ   SEQUENCE   292 AA;  33310 MW;  6516C9DB714F5A65 CRC64;
     MGNELFLAFT TSHLPLAEQK LARYKLRIVK PPKLPLEKKP NPDKDGPDYE PNLWMWVNPN
     IVYPPGKLEV SGRRKREDLT STLPSSQPPQ KEEDASCSEA AGVESLSQSS SKRSPPRKRF
     AFSPSTWELT EEEEAEDQED SSSMALPSPH KRAPLQSRRL RQASSQAGRL WSRPPLNYFH
     LIALALRNSS PCGLNVQQIY SFTRKHFPFF RTAPEGWKNT VRHNLCFRDS FEKVPVSMQG
     GASTRPRSCL WKLTEEGHRR FAEEARALAS TRLESIQQCM SQPDVMPFLF DL
//
ID   B4DNF7_HUMAN            Unreviewed;       574 AA.
AC   B4DNF7;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   31-JAN-2018, entry version 51.
DE   SubName: Full=cDNA FLJ57539, highly similar to Zinc finger protein GLI1 {ECO:0000313|EMBL:BAG60219.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG60219.1};
RN   [1] {ECO:0000313|EMBL:BAG60219.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Whole embryo {ECO:0000313|EMBL:BAG60219.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK297899; BAG60219.1; -; mRNA.
DR   RefSeq; NP_001153517.1; NM_001160045.1.
DR   UniGene; Hs.632702; -.
DR   PeptideAtlas; B4DNF7; -.
DR   PRIDE; B4DNF7; -.
DR   GeneID; 2735; -.
DR   CTD; 2735; -.
DR   PharmGKB; PA28720; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   HOGENOM; HOG000169645; -.
DR   HOVERGEN; HBG080668; -.
DR   GenomeRNAi; 2735; -.
DR   Genevisible; B4DNF7; HS.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IEA:InterPro.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:InterPro.
DR   GO; GO:0007224; P:smoothened signaling pathway; IEA:InterPro.
DR   InterPro; IPR032850; GLI1.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR19818:SF2; PTHR19818:SF2; 2.
DR   SMART; SM00355; ZnF_C2H2; 5.
DR   SUPFAM; SSF57667; SSF57667; 3.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 4.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 5.
PE   2: Evidence at transcript level;
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00042};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00042};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00042}.
FT   DOMAIN      107    139       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      140    172       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      173    202       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      203    233       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      234    264       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
SQ   SEQUENCE   574 AA;  62989 MW;  B98EC21168AA64A6 CRC64;
     MSPSLGFPAQ MNHQKGPSPS FGVQPCGPHD SARGGMIPHP QSRGPFPTCQ LKSELDMLVG
     KCREEPLEGD MSSPNSTGIQ DPLLGMLDGR EDLEREEKRE PESVYETDCR WDGCSQEFDS
     QEQLVHHINS EHIHGERKEF VCHWGGCSRE LRPFKAQYML VVHMRRHTGE KPHKCTFEGC
     RKSYSRLENL KTHLRSHTGE KPYMCEHEGC SKAFSNASDR AKHQNRTHSN EKPYVCKLPG
     CTKRYTDPSS LRKHVKTVHG PDAHVTKRHR GDGPLPRAPS ISTVEPKRER EGGPIREESR
     LTVPEGAMKP HPQPLFSHYP QPSPPQYLQS GPYTQPPPDY LPSEPRPCLD FDSPTHSTGQ
     LKAQLVCNYV QSQQELLWEG GGREDAPAQE PSYQSPKFLG GSQVSPSRAK APVNTYGPGF
     GPNLPNHKSG SYPTPSPCHE NFVVGANRAS HRAAAPPRLL PPLPTCYGPL KVGGTNPSCG
     HPEVGRLGGG PALYPPPEGQ VCNPLDSLDL DNTQLDFVAI LDEPQGLSPP PSHDQRGSSG
     HTPPPSGPPN MAVGNMSVLL RSLPGETEFL NSSA
//
ID   GLI1_HUMAN              Reviewed;        1106 AA.
AC   P08151; D0EUY3; E9PQQ9; F5H6H8; Q8TDN9;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1988, sequence version 1.
DT   25-APR-2018, entry version 203.
DE   RecName: Full=Zinc finger protein GLI1;
DE   AltName: Full=Glioma-associated oncogene;
DE   AltName: Full=Oncogene GLI;
GN   Name=GLI1; Synonyms=GLI;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2832761; DOI=10.1038/332371a0;
RA   Kinzler K.W., Ruppert J.M., Bigner S.H., Vogelstein B.;
RT   "The GLI gene is a member of the Kruppel family of zinc finger
RT   proteins.";
RL   Nature 332:371-374(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ASP-933 AND GLN-1100.
RA   Yoon J.W., Kent P., Clark A., Patterson J., Villavicencio E.,
RA   Iannaccone P., Walterhouse D.;
RT   "Polymorphic variants of the human oncogene GLI1 function similarly.";
RL   Submitted (OCT-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), ALTERNATIVE SPLICING,
RP   FUNCTION, SUBCELLULAR LOCATION, INDUCTION, AND TISSUE SPECIFICITY.
RX   PubMed=19706761; DOI=10.1158/0008-5472.CAN-09-0886;
RA   Lo H.W., Zhu H., Cao X., Aldrich A., Ali-Osman F.;
RT   "A novel splice variant of GLI1 that promotes glioblastoma cell
RT   migration and invasion.";
RL   Cancer Res. 69:6790-6798(2009).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, AND DNA-BINDING.
RX   PubMed=2105456; DOI=10.1128/MCB.10.2.634;
RA   Kinzler K.W., Vogelstein B.;
RT   "The GLI gene encodes a nuclear protein which binds specific sequences
RT   in the human genome.";
RL   Mol. Cell. Biol. 10:634-642(1990).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH STK36 AND SUFU.
RX   PubMed=10806483; DOI=10.1038/35010610;
RA   Murone M., Luoh S.-L., Stone D., Li W., Gurney A., Armanini M.,
RA   Grey C., Rosenthal A., de Sauvage F.J.;
RT   "Gli regulation by the opposing activities of fused and suppressor of
RT   fused.";
RL   Nat. Cell Biol. 2:310-312(2000).
RN   [8]
RP   FUNCTION, INTERACTION WITH ZIC1, AND SUBCELLULAR LOCATION.
RX   PubMed=11238441; DOI=10.1074/jbc.C000773200;
RA   Koyabu Y., Nakata K., Mizugishi K., Aruga J., Mikoshiba K.;
RT   "Physical and functional interactions between Zic and Gli proteins.";
RL   J. Biol. Chem. 276:6889-6892(2001).
RN   [9]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, PHOSPHORYLATION, AND
RP   FUNCTION.
RX   PubMed=19878745; DOI=10.1016/j.yexcr.2009.10.018;
RA   Maloverjan A., Piirsoo M., Michelson P., Kogerman P., Osterlund T.;
RT   "Identification of a novel serine/threonine kinase ULK3 as a positive
RT   regulator of Hedgehog pathway.";
RL   Exp. Cell Res. 316:627-637(2010).
RN   [10]
RP   ACETYLATION AT LYS-518.
RX   PubMed=20081843; DOI=10.1038/ncb2013;
RA   Canettieri G., Di Marcotullio L., Greco A., Coni S., Antonucci L.,
RA   Infante P., Pietrosanti L., De Smaele E., Ferretti E., Miele E.,
RA   Pelloni M., De Simone G., Pedone E.M., Gallinari P., Giorgi A.,
RA   Steinkuhler C., Vitagliano L., Pedone C., Schinin M.E., Screpanti I.,
RA   Gulino A.;
RT   "Histone deacetylase and Cullin3-REN(KCTD11) ubiquitin ligase
RT   interplay regulates Hedgehog signalling through Gli acetylation.";
RL   Nat. Cell Biol. 12:132-142(2010).
RN   [11]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1003, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 234-388 IN COMPLEX WITH DNA,
RP   AND DNA-BINDING.
RX   PubMed=8378770; DOI=10.1126/science.8378770;
RA   Pavletich N.P., Pabo C.O.;
RT   "Crystal structure of a five-finger GLI-DNA complex: new perspectives
RT   on zinc fingers.";
RL   Science 261:1701-1707(1993).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) OF 115-131 IN COMPLEX WITH
RP   SUFU, INTERACTION WITH SUFU, AND FUNCTION.
RX   PubMed=24311597; DOI=10.1107/S0907444913028473;
RA   Cherry A.L., Finta C., Karlstrom M., Jin Q., Schwend T.,
RA   Astorga-Wells J., Zubarev R.A., Del Campo M., Criswell A.R.,
RA   de Sanctis D., Jovine L., Toftgard R.;
RT   "Structural basis of SUFU-GLI interaction in human Hedgehog signalling
RT   regulation.";
RL   Acta Crystallogr. D 69:2563-2579(2013).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 112-128 IN COMPLEX WITH
RP   SUFU, INTERACTION WITH SUFU, AND FUNCTION.
RX   PubMed=24217340; DOI=10.1038/ncomms3608;
RA   Zhang Y., Fu L., Qi X., Zhang Z., Xia Y., Jia J., Jiang J., Zhao Y.,
RA   Wu G.;
RT   "Structural insight into the mutual recognition and regulation between
RT   Suppressor of Fused and Gli/Ci.";
RL   Nat. Commun. 4:2608-2608(2013).
RN   [15]
RP   VARIANTS ALA-884; ASP-933 AND GLN-1100.
RX   PubMed=10951255; DOI=10.1046/j.1523-1747.2000.00065.x;
RA   Wang X.Q., Chan N., Rothnagel J.A.;
RT   "Identification of polymorphic variants of the GLI1 oncogene.";
RL   J. Invest. Dermatol. 115:328-329(2000).
RN   [16]
RP   VARIANTS [LARGE SCALE ANALYSIS] ALA-210; ILE-514 AND GLN-817.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Acts as a transcriptional activator (PubMed:19706761,
CC       PubMed:10806483, PubMed:19878745, PubMed:24311597,
CC       PubMed:24217340). Binds to the DNA consensus sequence 5'-
CC       GACCACCCA-3' (PubMed:2105456, PubMed:8378770, PubMed:24217340).
CC       May regulate the transcription of specific genes during normal
CC       development (PubMed:19706761). May play a role in craniofacial
CC       development and digital development, as well as development of the
CC       central nervous system and gastrointestinal tract. Mediates SHH
CC       signaling (PubMed:19706761). Plays a role in cell proliferation
CC       and differentiation via its role in SHH signaling (Probable).
CC       {ECO:0000269|PubMed:10806483, ECO:0000269|PubMed:11238441,
CC       ECO:0000269|PubMed:19706761, ECO:0000269|PubMed:19878745,
CC       ECO:0000269|PubMed:2105456, ECO:0000269|PubMed:24217340,
CC       ECO:0000269|PubMed:24311597, ECO:0000269|PubMed:8378770,
CC       ECO:0000305}.
CC   -!- FUNCTION: Isoform 2: Acts as a transcriptional activator, but
CC       activates a different set of genes than isoform 1. Activates
CC       expression of CD24, unlike isoform 1. Mediates SHH signaling.
CC       Promotes cancer cell migration. {ECO:0000269|PubMed:19706761}.
CC   -!- SUBUNIT: Interacts with KIF7 (By similarity). Interacts with STK36
CC       (PubMed:10806483). Interacts with ZIC1; the interaction enhances
CC       transcription activation (PubMed:11238441). Interacts with SUFU;
CC       this inhibits transcriptional activation by GLI1 (PubMed:10806483,
CC       PubMed:24311597, PubMed:24217340). {ECO:0000250|UniProtKB:P47806,
CC       ECO:0000269|PubMed:10806483, ECO:0000269|PubMed:11238441,
CC       ECO:0000269|PubMed:24217340, ECO:0000269|PubMed:24311597}.
CC   -!- INTERACTION:
CC       P29972:AQP1; NbExp=4; IntAct=EBI-308084, EBI-745213;
CC       Q8NEC5:CATSPER1; NbExp=4; IntAct=EBI-308084, EBI-744545;
CC       P53673:CRYBA4; NbExp=3; IntAct=EBI-308084, EBI-7519711;
CC       Q96CN9:GCC1; NbExp=3; IntAct=EBI-308084, EBI-746252;
CC       Q96J02:ITCH; NbExp=4; IntAct=EBI-308084, EBI-1564678;
CC       Q9QZS3-2:Numb (xeno); NbExp=4; IntAct=EBI-308084, EBI-3896014;
CC       P54646:PRKAA2; NbExp=3; IntAct=EBI-308084, EBI-1383852;
CC       P41743:PRKCI; NbExp=3; IntAct=EBI-16038799, EBI-286199;
CC       P23443:RPS6KB1; NbExp=4; IntAct=EBI-308084, EBI-1775921;
CC       P23443-2:RPS6KB1; NbExp=2; IntAct=EBI-308084, EBI-6093204;
CC       Q9NRP7:STK36; NbExp=2; IntAct=EBI-308084, EBI-863797;
CC       Q9UMX1:SUFU; NbExp=25; IntAct=EBI-308084, EBI-740595;
CC       Q9UMX1-1:SUFU; NbExp=2; IntAct=EBI-308084, EBI-740615;
CC       Q9UMX1-2:SUFU; NbExp=4; IntAct=EBI-308084, EBI-740621;
CC       Q8IWZ5:TRIM42; NbExp=3; IntAct=EBI-308084, EBI-5235829;
CC       P40337-1:VHL; NbExp=2; IntAct=EBI-308084, EBI-3504450;
CC       P40337-3:VHL; NbExp=2; IntAct=EBI-308084, EBI-301270;
CC       P46684:Zic1 (xeno); NbExp=2; IntAct=EBI-308084, EBI-308006;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10806483,
CC       ECO:0000269|PubMed:19706761, ECO:0000269|PubMed:19878745}. Nucleus
CC       {ECO:0000269|PubMed:10806483, ECO:0000269|PubMed:11238441,
CC       ECO:0000269|PubMed:19706761, ECO:0000269|PubMed:19878745,
CC       ECO:0000269|PubMed:2105456}. Note=Tethered in the cytoplasm by
CC       binding to SUFU (PubMed:10806483). Activation and translocation to
CC       the nucleus is promoted by interaction with STK36
CC       (PubMed:10806483). Phosphorylation by ULK3 may promote nuclear
CC       localization (PubMed:19878745). Translocation to the nucleus is
CC       promoted by interaction with ZIC1 (PubMed:11238441).
CC       {ECO:0000269|PubMed:10806483, ECO:0000269|PubMed:11238441,
CC       ECO:0000269|PubMed:19878745}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Cytoplasm
CC       {ECO:0000269|PubMed:19706761}. Nucleus
CC       {ECO:0000269|PubMed:19706761}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P08151-1; Sequence=Displayed;
CC       Name=2; Synonyms=tGLI1;
CC         IsoId=P08151-2; Sequence=VSP_042215;
CC         Note=Undetectable in normal cells but highly expressed in cancer
CC         cells.;
CC       Name=3;
CC         IsoId=P08151-3; Sequence=VSP_054829;
CC         Note=No experimental confirmation available. Gene prediction
CC         based on partial mRNA and EST data.;
CC   -!- TISSUE SPECIFICITY: Detected in testis (at protein level)
CC       (PubMed:2105456). Testis, myometrium and fallopian tube. Also
CC       expressed in the brain with highest expression in the cerebellum,
CC       optic nerve and olfactory tract (PubMed:19878745). Isoform 1 is
CC       detected in brain, spleen, pancreas, liver, kidney and placenta;
CC       isoform 2 is not detectable in these tissues (PubMed:19706761).
CC       {ECO:0000269|PubMed:19706761, ECO:0000269|PubMed:19878745,
CC       ECO:0000269|PubMed:2105456}.
CC   -!- INDUCTION: Isoform 1 and isoform 2 are amplified in glioblastoma
CC       cells. {ECO:0000269|PubMed:19706761}.
CC   -!- PTM: Phosphorylated in vitro by ULK3.
CC       {ECO:0000269|PubMed:19878745}.
CC   -!- PTM: Acetylation at Lys-518 down-regulates transcriptional
CC       activity. Deacetylated by HDAC1. {ECO:0000269|PubMed:20081843}.
CC   -!- SIMILARITY: Belongs to the GLI C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/GLIID310ch12q13.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X07384; CAA30297.1; -; mRNA.
DR   EMBL; AF316573; AAM13391.1; -; Genomic_DNA.
DR   EMBL; GQ890670; ACX35434.1; -; mRNA.
DR   EMBL; AC022506; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC013000; AAH13000.1; -; mRNA.
DR   CCDS; CCDS53806.1; -. [P08151-2]
DR   CCDS; CCDS53807.1; -. [P08151-3]
DR   CCDS; CCDS8940.1; -. [P08151-1]
DR   PIR; S00672; TVHUGL.
DR   RefSeq; NP_001153517.1; NM_001160045.1. [P08151-3]
DR   RefSeq; NP_001161081.1; NM_001167609.1. [P08151-2]
DR   RefSeq; NP_005260.1; NM_005269.2. [P08151-1]
DR   RefSeq; XP_011536491.1; XM_011538189.2. [P08151-1]
DR   UniGene; Hs.632702; -.
DR   PDB; 2GLI; X-ray; 2.60 A; A=234-388.
DR   PDB; 4BLB; X-ray; 2.80 A; E/F/G/H=115-131.
DR   PDB; 4KMD; X-ray; 1.70 A; B=112-128.
DR   PDB; 5OM0; X-ray; 3.20 A; A/B=637-645.
DR   PDBsum; 2GLI; -.
DR   PDBsum; 4BLB; -.
DR   PDBsum; 4KMD; -.
DR   PDBsum; 5OM0; -.
DR   ProteinModelPortal; P08151; -.
DR   SMR; P08151; -.
DR   BioGrid; 108997; 68.
DR   DIP; DIP-32536N; -.
DR   ELM; P08151; -.
DR   IntAct; P08151; 41.
DR   MINT; P08151; -.
DR   STRING; 9606.ENSP00000228682; -.
DR   BindingDB; P08151; -.
DR   ChEMBL; CHEMBL5461; -.
DR   iPTMnet; P08151; -.
DR   PhosphoSitePlus; P08151; -.
DR   BioMuta; GLI1; -.
DR   DMDM; 121323; -.
DR   MaxQB; P08151; -.
DR   PaxDb; P08151; -.
DR   PeptideAtlas; P08151; -.
DR   PRIDE; P08151; -.
DR   Ensembl; ENST00000228682; ENSP00000228682; ENSG00000111087. [P08151-1]
DR   Ensembl; ENST00000528467; ENSP00000434408; ENSG00000111087. [P08151-2]
DR   Ensembl; ENST00000543426; ENSP00000437607; ENSG00000111087. [P08151-3]
DR   Ensembl; ENST00000546141; ENSP00000441006; ENSG00000111087. [P08151-2]
DR   GeneID; 2735; -.
DR   KEGG; hsa:2735; -.
DR   UCSC; uc001snx.4; human. [P08151-1]
DR   CTD; 2735; -.
DR   DisGeNET; 2735; -.
DR   EuPathDB; HostDB:ENSG00000111087.9; -.
DR   GeneCards; GLI1; -.
DR   H-InvDB; HIX0010767; -.
DR   HGNC; HGNC:4317; GLI1.
DR   HPA; CAB009460; -.
DR   HPA; HPA065172; -.
DR   MIM; 165220; gene.
DR   neXtProt; NX_P08151; -.
DR   OpenTargets; ENSG00000111087; -.
DR   PharmGKB; PA28720; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   GeneTree; ENSGT00900000140802; -.
DR   HOGENOM; HOG000290688; -.
DR   HOVERGEN; HBG080668; -.
DR   InParanoid; P08151; -.
DR   KO; K16797; -.
DR   OMA; VTKRHRG; -.
DR   OrthoDB; EOG091G01XS; -.
DR   PhylomeDB; P08151; -.
DR   TreeFam; TF350216; -.
DR   Reactome; R-HSA-5610780; Degradation of GLI1 by the proteasome.
DR   Reactome; R-HSA-5610787; Hedgehog 'off' state.
DR   Reactome; R-HSA-5632684; Hedgehog 'on' state.
DR   Reactome; R-HSA-5635851; GLI proteins bind promoters of Hh responsive genes to promote transcription.
DR   SignaLink; P08151; -.
DR   SIGNOR; P08151; -.
DR   EvolutionaryTrace; P08151; -.
DR   GeneWiki; GLI1; -.
DR   GenomeRNAi; 2735; -.
DR   PRO; PR:P08151; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000111087; -.
DR   CleanEx; HS_GLI1; -.
DR   ExpressionAtlas; P08151; baseline and differential.
DR   Genevisible; P08151; HS.
DR   GO; GO:0005930; C:axoneme; IEA:Ensembl.
DR   GO; GO:0097546; C:ciliary base; TAS:Reactome.
DR   GO; GO:0097542; C:ciliary tip; TAS:Reactome.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IDA:MGI.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008017; F:microtubule binding; IEA:Ensembl.
DR   GO; GO:0000978; F:RNA polymerase II proximal promoter sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:MGI.
DR   GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; NAS:NTNU_SB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0003705; F:transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB.
DR   GO; GO:0060070; P:canonical Wnt signaling pathway; IEA:Ensembl.
DR   GO; GO:0021696; P:cerebellar cortex morphogenesis; IEA:Ensembl.
DR   GO; GO:0048546; P:digestive tract morphogenesis; TAS:BHF-UCL.
DR   GO; GO:0009953; P:dorsal/ventral pattern formation; IEA:Ensembl.
DR   GO; GO:0009913; P:epidermal cell differentiation; IDA:UniProtKB.
DR   GO; GO:0097421; P:liver regeneration; IEA:Ensembl.
DR   GO; GO:0030324; P:lung development; IEA:Ensembl.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IMP:UniProtKB.
DR   GO; GO:0060032; P:notochord regression; IEA:Ensembl.
DR   GO; GO:0001649; P:osteoblast differentiation; IDA:UniProtKB.
DR   GO; GO:0021983; P:pituitary gland development; IEA:Ensembl.
DR   GO; GO:0060045; P:positive regulation of cardiac muscle cell proliferation; IDA:BHF-UCL.
DR   GO; GO:1902808; P:positive regulation of cell cycle G1/S phase transition; IDA:BHF-UCL.
DR   GO; GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB.
DR   GO; GO:0045740; P:positive regulation of DNA replication; IDA:UniProtKB.
DR   GO; GO:0045880; P:positive regulation of smoothened signaling pathway; IDA:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0030850; P:prostate gland development; IEA:Ensembl.
DR   GO; GO:0009954; P:proximal/distal pattern formation; IEA:Ensembl.
DR   GO; GO:2000345; P:regulation of hepatocyte proliferation; IEA:Ensembl.
DR   GO; GO:0045667; P:regulation of osteoblast differentiation; IEA:Ensembl.
DR   GO; GO:0008589; P:regulation of smoothened signaling pathway; TAS:UniProtKB.
DR   GO; GO:0009611; P:response to wounding; IEA:Ensembl.
DR   GO; GO:0007224; P:smoothened signaling pathway; IDA:UniProtKB.
DR   GO; GO:0021938; P:smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation; IEA:Ensembl.
DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0007418; P:ventral midline development; IEA:Ensembl.
DR   InterPro; IPR032850; GLI1.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR19818:SF2; PTHR19818:SF2; 1.
DR   SMART; SM00355; ZnF_C2H2; 5.
DR   SUPFAM; SSF57667; SSF57667; 3.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 4.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 5.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activator; Alternative splicing;
KW   Complete proteome; Cytoplasm; Developmental protein; Differentiation;
KW   DNA-binding; Isopeptide bond; Metal-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Proto-oncogene; Reference proteome; Repeat;
KW   Transcription; Transcription regulation; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   CHAIN         1   1106       Zinc finger protein GLI1.
FT                                /FTId=PRO_0000047197.
FT   ZN_FING     235    260       C2H2-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     268    295       C2H2-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     301    325       C2H2-type 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     331    356       C2H2-type 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     362    387       C2H2-type 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   REGION        1     20       SNAG domain. {ECO:0000250}.
FT   REGION      120    124       Interaction with SUFU.
FT                                {ECO:0000269|PubMed:24217340,
FT                                ECO:0000269|PubMed:24311597}.
FT   REGION      283    291       Interaction with DNA.
FT                                {ECO:0000269|PubMed:8378770}.
FT   REGION      345    350       Interaction with DNA.
FT                                {ECO:0000269|PubMed:8378770}.
FT   REGION      375    381       Interaction with DNA.
FT                                {ECO:0000269|PubMed:8378770}.
FT   COMPBIAS   1038   1055       Asp/Glu-rich (acidic).
FT   MOD_RES     518    518       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:20081843}.
FT   CROSSLNK   1003   1003       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ       1    128       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_054829.
FT   VAR_SEQ      34     74       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:19706761}.
FT                                /FTId=VSP_042215.
FT   VARIANT     210    210       P -> A (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035557.
FT   VARIANT     514    514       T -> I (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035558.
FT   VARIANT     817    817       E -> Q (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035559.
FT   VARIANT     884    884       D -> A. {ECO:0000269|PubMed:10951255}.
FT                                /FTId=VAR_015114.
FT   VARIANT     933    933       G -> D (in dbSNP:rs2228224).
FT                                {ECO:0000269|PubMed:10951255,
FT                                ECO:0000269|Ref.2}.
FT                                /FTId=VAR_015115.
FT   VARIANT    1012   1012       G -> V (in dbSNP:rs2229300).
FT                                /FTId=VAR_052723.
FT   VARIANT    1100   1100       E -> Q (in dbSNP:rs2228226).
FT                                {ECO:0000269|PubMed:10951255,
FT                                ECO:0000269|Ref.2}.
FT                                /FTId=VAR_015116.
FT   CONFLICT   1106   1106       A -> AS (in Ref. 3; ACX35434).
FT                                {ECO:0000305}.
FT   STRAND      120    123       {ECO:0000244|PDB:4KMD}.
FT   HELIX       249    259       {ECO:0000244|PDB:2GLI}.
FT   STRAND      261    263       {ECO:0000244|PDB:2GLI}.
FT   TURN        276    279       {ECO:0000244|PDB:2GLI}.
FT   HELIX       285    291       {ECO:0000244|PDB:2GLI}.
FT   HELIX       293    296       {ECO:0000244|PDB:2GLI}.
FT   HELIX       315    324       {ECO:0000244|PDB:2GLI}.
FT   STRAND      341    346       {ECO:0000244|PDB:2GLI}.
FT   HELIX       349    354       {ECO:0000244|PDB:2GLI}.
FT   TURN        367    369       {ECO:0000244|PDB:2GLI}.
FT   STRAND      372    375       {ECO:0000244|PDB:2GLI}.
FT   HELIX       376    381       {ECO:0000244|PDB:2GLI}.
FT   TURN        382    384       {ECO:0000244|PDB:2GLI}.
SQ   SEQUENCE   1106 AA;  117904 MW;  E29B11D1A6CD3D91 CRC64;
     MFNSMTPPPI SSYGEPCCLR PLPSQGAPSV GTEGLSGPPF CHQANLMSGP HSYGPARETN
     SCTEGPLFSS PRSAVKLTKK RALSISPLSD ASLDLQTVIR TSPSSLVAFI NSRCTSPGGS
     YGHLSIGTMS PSLGFPAQMN HQKGPSPSFG VQPCGPHDSA RGGMIPHPQS RGPFPTCQLK
     SELDMLVGKC REEPLEGDMS SPNSTGIQDP LLGMLDGRED LEREEKREPE SVYETDCRWD
     GCSQEFDSQE QLVHHINSEH IHGERKEFVC HWGGCSRELR PFKAQYMLVV HMRRHTGEKP
     HKCTFEGCRK SYSRLENLKT HLRSHTGEKP YMCEHEGCSK AFSNASDRAK HQNRTHSNEK
     PYVCKLPGCT KRYTDPSSLR KHVKTVHGPD AHVTKRHRGD GPLPRAPSIS TVEPKREREG
     GPIREESRLT VPEGAMKPQP SPGAQSSCSS DHSPAGSAAN TDSGVEMTGN AGGSTEDLSS
     LDEGPCIAGT GLSTLRRLEN LRLDQLHQLR PIGTRGLKLP SLSHTGTTVS RRVGPPVSLE
     RRSSSSSSIS SAYTVSRRSS LASPFPPGSP PENGASSLPG LMPAQHYLLR ARYASARGGG
     TSPTAASSLD RIGGLPMPPW RSRAEYPGYN PNAGVTRRAS DPAQAADRPA PARVQRFKSL
     GCVHTPPTVA GGGQNFDPYL PTSVYSPQPP SITENAAMDA RGLQEEPEVG TSMVGSGLNP
     YMDFPPTDTL GYGGPEGAAA EPYGARGPGS LPLGPGPPTN YGPNPCPQQA SYPDPTQETW
     GEFPSHSGLY PGPKALGGTY SQCPRLEHYG QVQVKPEQGC PVGSDSTGLA PCLNAHPSEG
     PPHPQPLFSH YPQPSPPQYL QSGPYTQPPP DYLPSEPRPC LDFDSPTHST GQLKAQLVCN
     YVQSQQELLW EGGGREDAPA QEPSYQSPKF LGGSQVSPSR AKAPVNTYGP GFGPNLPNHK
     SGSYPTPSPC HENFVVGANR ASHRAAAPPR LLPPLPTCYG PLKVGGTNPS CGHPEVGRLG
     GGPALYPPPE GQVCNPLDSL DLDNTQLDFV AILDEPQGLS PPPSHDQRGS SGHTPPPSGP
     PNMAVGNMSV LLRSLPGETE FLNSSA
//
ID   TEC_HUMAN               Reviewed;         631 AA.
AC   P42680; B7ZKZ6; Q3MIS5;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   11-SEP-2007, sequence version 2.
DT   28-MAR-2018, entry version 181.
DE   RecName: Full=Tyrosine-protein kinase Tec;
DE            EC=2.7.10.2;
GN   Name=TEC; Synonyms=PSCTK4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Blood;
RX   PubMed=7934162;
RA   Sato K., Mano H., Ariyama T., Inazawa J., Yazaki Y., Hirai H.;
RT   "Molecular cloning and analysis of the human Tec protein-tyrosine
RT   kinase.";
RL   Leukemia 8:1663-1672(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 203-206, AND PHOSPHORYLATION AT TYR-206.
RX   PubMed=12573241; DOI=10.1016/S1570-9639(02)00524-1;
RA   Nore B.F., Mattsson P.T., Antonsson P., Backesjo C.-M., Westlund A.,
RA   Lennartsson J., Hansson H., Low P., Ronnstrand L., Smith C.I.E.;
RT   "Identification of phosphorylation sites within the SH3 domains of Tec
RT   family tyrosine kinases.";
RL   Biochim. Biophys. Acta 1645:123-132(2003).
RN   [5]
RP   PHOSPHORYLATION, INTERACTION WITH KIT, AND ENZYME REGULATION.
RX   PubMed=7526158; DOI=10.1128/MCB.14.12.8432;
RA   Tang B., Mano H., Yi T., Ihle J.N.;
RT   "Tec kinase associates with c-kit and is tyrosine phosphorylated and
RT   activated following stem cell factor binding.";
RL   Mol. Cell. Biol. 14:8432-8437(1994).
RN   [6]
RP   PHOSPHORYLATION, AND SUBCELLULAR LOCATION.
RX   PubMed=9299487; DOI=10.1006/bbrc.1997.7269;
RA   Laffargue M., Monnereau L., Tuech J., Ragab A., Ragab-Thomas J.,
RA   Payrastre B., Raynal P., Chap H.;
RT   "Integrin-dependent tyrosine phosphorylation and cytoskeletal
RT   translocation of Tec in thrombin-activated platelets.";
RL   Biochem. Biophys. Res. Commun. 238:247-251(1997).
RN   [7]
RP   ENZYME REGULATION.
RX   PubMed=9341160; DOI=10.1074/jbc.272.43.27178;
RA   Ohya K., Kajigaya S., Yamashita Y., Miyazato A., Hatake K., Miura Y.,
RA   Ikeda U., Shimada K., Ozawa K., Mano H.;
RT   "SOCS-1/JAB/SSI-1 can bind to and suppress Tec protein-tyrosine
RT   kinase.";
RL   J. Biol. Chem. 272:27178-27182(1997).
RN   [8]
RP   INTERACTION WITH GRB10, AND FUNCTION IN PHOSPHORYLATION OF GRB10.
RX   PubMed=9753425; DOI=10.1046/j.1365-2443.1998.00201.x;
RA   Mano H., Ohya K., Miyazato A., Yamashita Y., Ogawa W., Inazawa J.,
RA   Ikeda U., Shimada K., Hatake K., Kasuga M., Ozawa K., Kajigaya S.;
RT   "Grb10/GrbIR as an in vivo substrate of Tec tyrosine kinase.";
RL   Genes Cells 3:431-441(1998).
RN   [9]
RP   PHOSPHORYLATION, ENZYME REGULATION, AND SUBCELLULAR LOCATION.
RX   PubMed=9652744; DOI=10.1038/sj.onc.1201799;
RA   Hamazaki Y., Kojima H., Mano H., Nagata Y., Todokoro K., Abe T.,
RA   Nagasawa T.;
RT   "Tec is involved in G protein-coupled receptor- and integrin-mediated
RT   signalings in human blood platelets.";
RL   Oncogene 16:2773-2779(1998).
RN   [10]
RP   FUNCTION IN PHOSPHORYLATION OF STAP1, AND ENZYME REGULATION.
RX   PubMed=10518561; DOI=10.1073/pnas.96.21.11976;
RA   Ohya K., Kajigaya S., Kitanaka A., Yoshida K., Miyazato A.,
RA   Yamashita Y., Yamanaka T., Ikeda U., Shimada K., Ozawa K., Mano H.;
RT   "Molecular cloning of a docking protein, BRDG1, that acts downstream
RT   of the Tec tyrosine kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:11976-11981(1999).
RN   [11]
RP   INTERACTION WITH INPP5D AND INPPL1.
RX   PubMed=15492005; DOI=10.1074/jbc.M408141200;
RA   Tomlinson M.G., Heath V.L., Turck C.W., Watson S.P., Weiss A.;
RT   "SHIP family inositol phosphatases interact with and negatively
RT   regulate the Tec tyrosine kinase.";
RL   J. Biol. Chem. 279:55089-55096(2004).
RN   [12]
RP   INTERACTION WITH FASLG.
RX   PubMed=19807924; DOI=10.1186/1471-2172-10-53;
RA   Voss M., Lettau M., Janssen O.;
RT   "Identification of SH3 domain interaction partners of human FasL
RT   (CD178) by phage display screening.";
RL   BMC Immunol. 10:53-53(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-206 AND TYR-228, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-519, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   FUNCTION.
RX   PubMed=19883687; DOI=10.1016/j.imlet.2009.10.009;
RA   Susaki K., Kitanaka A., Dobashi H., Kubota Y., Kittaka K., Kameda T.,
RA   Yamaoka G., Mano H., Mihara K., Ishida T.;
RT   "Tec protein tyrosine kinase inhibits CD25 expression in human T-
RT   lymphocyte.";
RL   Immunol. Lett. 127:135-142(2010).
RN   [16]
RP   FUNCTION IN PHOSPHORYLATION OF FGF2, AND INTERACTION WITH FGF2.
RX   PubMed=20230531; DOI=10.1111/j.1600-0854.2010.01059.x;
RA   Ebert A.D., Laussmann M., Wegehingel S., Kaderali L., Erfle H.,
RA   Reichert J., Lechner J., Beer H.D., Pepperkok R., Nickel W.;
RT   "Tec-kinase-mediated phosphorylation of fibroblast growth factor 2 is
RT   essential for unconventional secretion.";
RL   Traffic 11:813-826(2010).
RN   [17]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLN-44 AND LYS-563.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Non-receptor tyrosine kinase that contributes to
CC       signaling from many receptors and participates as a signal
CC       transducer in multiple downstream pathways, including regulation
CC       of the actin cytoskeleton. Plays a redundant role to ITK in
CC       regulation of the adaptive immune response. Regulates the
CC       development, function and differentiation of conventional T-cells
CC       and nonconventional NKT-cells. Required for TCR-dependent IL2 gene
CC       induction. Phosphorylates DOK1, one CD28-specific substrate, and
CC       contributes to CD28-signaling. Mediates signals that negatively
CC       regulate IL2RA expression induced by TCR cross-linking. Plays a
CC       redundant role to BTK in BCR-signaling for B-cell development and
CC       activation, especially by phosphorylating STAP1, a BCR-signaling
CC       protein. Required in mast cells for efficient cytokine production.
CC       Involved in both growth and differentiation mechanisms of myeloid
CC       cells through activation by the granulocyte colony-stimulating
CC       factor CSF3, a critical cytokine to promoting the growth,
CC       differentiation, and functional activation of myeloid cells.
CC       Participates in platelet signaling downstream of integrin
CC       activation. Cooperates with JAK2 through reciprocal
CC       phosphorylation to mediate cytokine-driven activation of FOS
CC       transcription. GRB10, a negative modifier of the FOS activation
CC       pathway, is another substrate of TEC. TEC is involved in G
CC       protein-coupled receptor- and integrin-mediated signalings in
CC       blood platelets. Plays a role in hepatocyte proliferation and
CC       liver regeneration and is involved in HGF-induced ERK signaling
CC       pathway. TEC regulates also FGF2 unconventional secretion
CC       (endoplasmic reticulum (ER)/Golgi-independent mechanism) under
CC       various physiological conditions through phosphorylation of FGF2
CC       'Tyr-215'. May also be involved in the regulation of osteoclast
CC       differentiation. {ECO:0000269|PubMed:10518561,
CC       ECO:0000269|PubMed:19883687, ECO:0000269|PubMed:20230531,
CC       ECO:0000269|PubMed:9753425}.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000255|PROSITE-
CC       ProRule:PRU10028}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250};
CC   -!- ENZYME REGULATION: Activated by tyrosine phosphorylation by a wide
CC       range of cytokine stimulations. When T-cells or B-cells receptors
CC       are activated, a series of phosphorylation leads to the
CC       recruitment of TEC to the cell membrane, where it is
CC       phosphorylated at Tyr-519. Also activated in response to SCF.
CC       Integrin engagement induces tyrosine phosphorylation of TEC in
CC       platelets. STAP1 participates in a positive feedback loop by
CC       increasing the activity of TEC. SOCS1 is an inhibitor of TEC
CC       kinase activity. {ECO:0000269|PubMed:10518561,
CC       ECO:0000269|PubMed:7526158, ECO:0000269|PubMed:9341160,
CC       ECO:0000269|PubMed:9652744}.
CC   -!- SUBUNIT: Interacts with INPP5D/SHIP1 and INPPL1/SHIP2. Interacts
CC       with CD28, FASLG, FGF2, GRB10, LYN and KIT. Interacts with VAV1
CC       and JAK2 (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q13480:GAB1; NbExp=2; IntAct=EBI-1383480, EBI-517684;
CC       P08581:MET; NbExp=2; IntAct=EBI-1383480, EBI-1039152;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cell membrane; Peripheral
CC       membrane protein. Cytoplasm, cytoskeleton. Note=Following B-cell
CC       or T-cell receptors activation by antigen, translocates to the
CC       plasma membrane through its PH domain. Thrombin and integrin
CC       engagement induces translocation of TEC to the cytoskeleton during
CC       platelet activation. In cardiac myocytes, assumes a diffuse
CC       intracellular localization under basal conditions but is recruited
CC       to striated structures upon various stimuli, including ATP (By
CC       similarity). {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in a wide range of cells, including
CC       hematopoietic cell lines like myeloid, B-, and T-cell lineages.
CC   -!- DOMAIN: The PH domain mediates the binding to inositol
CC       polyphosphate and phosphoinositides, leading to its targeting to
CC       the plasma membrane. It is extended in the BTK kinase family by a
CC       region designated the TH (Tec homology) domain, which consists of
CC       about 80 residues preceding the SH3 domain.
CC   -!- DOMAIN: The SH3 domain is essential for its targeting to activated
CC       CD28 costimulatory molecule. {ECO:0000250}.
CC   -!- PTM: Following B-cell or T-cell receptors engagement, translocates
CC       to the plasma membrane where it gets phosphorylated at Tyr-519.
CC       Undergoes also tyrosine phosphorylation during platelet
CC       activation. {ECO:0000269|PubMed:12573241,
CC       ECO:0000269|PubMed:7526158, ECO:0000269|PubMed:9299487,
CC       ECO:0000269|PubMed:9652744}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. TEC subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -!- CAUTION: It is uncertain whether Met-1 is the initiator.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D29767; BAA06171.1; -; mRNA.
DR   EMBL; CH471069; EAW93055.1; -; Genomic_DNA.
DR   EMBL; BC101711; AAI01712.1; -; mRNA.
DR   EMBL; BC101713; AAI01714.1; -; mRNA.
DR   EMBL; BC143487; AAI43488.1; -; mRNA.
DR   CCDS; CCDS3481.1; -.
DR   PIR; I38268; I38268.
DR   PIR; I56997; I56997.
DR   RefSeq; NP_003206.2; NM_003215.2.
DR   UniGene; Hs.479670; -.
DR   PDB; 2LUL; NMR; -; A=1-154.
DR   PDBsum; 2LUL; -.
DR   ProteinModelPortal; P42680; -.
DR   SMR; P42680; -.
DR   BioGrid; 112865; 23.
DR   IntAct; P42680; 18.
DR   MINT; P42680; -.
DR   STRING; 9606.ENSP00000370912; -.
DR   BindingDB; P42680; -.
DR   ChEMBL; CHEMBL4246; -.
DR   GuidetoPHARMACOLOGY; 2238; -.
DR   iPTMnet; P42680; -.
DR   PhosphoSitePlus; P42680; -.
DR   BioMuta; TEC; -.
DR   DMDM; 158518392; -.
DR   EPD; P42680; -.
DR   MaxQB; P42680; -.
DR   PaxDb; P42680; -.
DR   PeptideAtlas; P42680; -.
DR   PRIDE; P42680; -.
DR   DNASU; 7006; -.
DR   Ensembl; ENST00000381501; ENSP00000370912; ENSG00000135605.
DR   GeneID; 7006; -.
DR   KEGG; hsa:7006; -.
DR   UCSC; uc003gxz.4; human.
DR   CTD; 7006; -.
DR   DisGeNET; 7006; -.
DR   EuPathDB; HostDB:ENSG00000135605.12; -.
DR   GeneCards; TEC; -.
DR   HGNC; HGNC:11719; TEC.
DR   HPA; HPA005733; -.
DR   HPA; HPA024657; -.
DR   MalaCards; TEC; -.
DR   MIM; 600583; gene.
DR   neXtProt; NX_P42680; -.
DR   OpenTargets; ENSG00000135605; -.
DR   PharmGKB; PA36436; -.
DR   eggNOG; KOG0197; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   GeneTree; ENSGT00760000119011; -.
DR   HOGENOM; HOG000233859; -.
DR   HOVERGEN; HBG008761; -.
DR   InParanoid; P42680; -.
DR   KO; K07364; -.
DR   OMA; MKLTHPK; -.
DR   OrthoDB; EOG091G0D46; -.
DR   PhylomeDB; P42680; -.
DR   TreeFam; TF351634; -.
DR   BRENDA; 2.7.10.2; 2681.
DR   Reactome; R-HSA-1433557; Signaling by SCF-KIT.
DR   Reactome; R-HSA-2871809; FCERI mediated Ca+2 mobilization.
DR   Reactome; R-HSA-512988; Interleukin-3, 5 and GM-CSF signaling.
DR   SignaLink; P42680; -.
DR   SIGNOR; P42680; -.
DR   ChiTaRS; TEC; human.
DR   GeneWiki; TEC_(gene); -.
DR   GenomeRNAi; 7006; -.
DR   PRO; PR:P42680; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000135605; -.
DR   CleanEx; HS_TEC; -.
DR   ExpressionAtlas; P42680; baseline and differential.
DR   Genevisible; P42680; HS.
DR   GO; GO:0005856; C:cytoskeleton; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0031234; C:extrinsic component of cytoplasmic side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IDA:UniProtKB.
DR   GO; GO:0005543; F:phospholipid binding; NAS:BHF-UCL.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0050853; P:B cell receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0045087; P:innate immune response; IBA:GO_Central.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IDA:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; TAS:ProtInc.
DR   GO; GO:0038083; P:peptidyl-tyrosine autophosphorylation; IMP:BHF-UCL.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:BHF-UCL.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:BHF-UCL.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:ProtInc.
DR   GO; GO:0042127; P:regulation of cell proliferation; IBA:GO_Central.
DR   GO; GO:0010543; P:regulation of platelet activation; IDA:UniProtKB.
DR   GO; GO:0042246; P:tissue regeneration; IBA:GO_Central.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IBA:GO_Central.
DR   CDD; cd11905; SH3_Tec; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   Gene3D; 3.30.505.10; -; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR035572; Tec_SH3.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR001562; Znf_Btk_motif.
DR   Pfam; PF00779; BTK; 1.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF00017; SH2; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   PRINTS; PR00402; TECBTKDOMAIN.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00107; BTK; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00326; SH3; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   SUPFAM; SSF55550; SSF55550; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS50001; SH2; 1.
DR   PROSITE; PS50002; SH3; 1.
DR   PROSITE; PS51113; ZF_BTK; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Adaptive immunity; ATP-binding; Cell membrane;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Direct protein sequencing;
KW   Immunity; Kinase; Lipid-binding; Membrane; Metal-binding;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   SH2 domain; SH3 domain; Transferase; Tyrosine-protein kinase; Zinc;
KW   Zinc-finger.
FT   CHAIN         1    631       Tyrosine-protein kinase Tec.
FT                                /FTId=PRO_0000088170.
FT   DOMAIN        4    111       PH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00145}.
FT   DOMAIN      179    239       SH3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00192}.
FT   DOMAIN      247    345       SH2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00191}.
FT   DOMAIN      370    623       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ZN_FING     113    149       Btk-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00432}.
FT   NP_BIND     376    384       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    489    489       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10028}.
FT   METAL       121    121       Zinc. {ECO:0000250}.
FT   METAL       132    132       Zinc. {ECO:0000250}.
FT   METAL       133    133       Zinc. {ECO:0000250}.
FT   METAL       143    143       Zinc. {ECO:0000250}.
FT   BINDING     398    398       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     206    206       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000244|PubMed:19369195,
FT                                ECO:0000269|PubMed:12573241}.
FT   MOD_RES     228    228       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     519    519       Phosphotyrosine; by autocatalysis, LYN
FT                                and JAK2. {ECO:0000244|PubMed:19690332}.
FT   VARIANT      44     44       R -> Q (in dbSNP:rs35374286).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041850.
FT   VARIANT     563    563       R -> K (in a lung adenocarcinoma sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041851.
FT   CONFLICT    514    514       V -> F (in Ref. 1; BAA06171).
FT                                {ECO:0000305}.
FT   STRAND        3     14       {ECO:0000244|PDB:2LUL}.
FT   STRAND       19     21       {ECO:0000244|PDB:2LUL}.
FT   STRAND       26     41       {ECO:0000244|PDB:2LUL}.
FT   STRAND       45     47       {ECO:0000244|PDB:2LUL}.
FT   STRAND       53     55       {ECO:0000244|PDB:2LUL}.
FT   HELIX        56     58       {ECO:0000244|PDB:2LUL}.
FT   STRAND       61     64       {ECO:0000244|PDB:2LUL}.
FT   STRAND       69     71       {ECO:0000244|PDB:2LUL}.
FT   STRAND       74     76       {ECO:0000244|PDB:2LUL}.
FT   STRAND       78     83       {ECO:0000244|PDB:2LUL}.
FT   STRAND       88     92       {ECO:0000244|PDB:2LUL}.
FT   HELIX        96    110       {ECO:0000244|PDB:2LUL}.
FT   STRAND      118    120       {ECO:0000244|PDB:2LUL}.
FT   STRAND      132    134       {ECO:0000244|PDB:2LUL}.
FT   STRAND      143    145       {ECO:0000244|PDB:2LUL}.
SQ   SEQUENCE   631 AA;  73581 MW;  F55DECBF9916E1F9 CRC64;
     MNFNTILEEI LIKRSQQKKK TSPLNYKERL FVLTKSMLTY YEGRAEKKYR KGFIDVSKIK
     CVEIVKNDDG VIPCQNKYPF QVVHDANTLY IFAPSPQSRD LWVKKLKEEI KNNNNIMIKY
     HPKFWTDGSY QCCRQTEKLA PGCEKYNLFE SSIRKALPPA PETKKRRPPP PIPLEEEDNS
     EEIVVAMYDF QAAEGHDLRL ERGQEYLILE KNDVHWWRAR DKYGNEGYIP SNYVTGKKSN
     NLDQYEWYCR NMNRSKAEQL LRSEDKEGGF MVRDSSQPGL YTVSLYTKFG GEGSSGFRHY
     HIKETTTSPK KYYLAEKHAF GSIPEIIEYH KHNAAGLVTR LRYPVSVKGK NAPTTAGFSY
     EKWEINPSEL TFMRELGSGL FGVVRLGKWR AQYKVAIKAI REGAMCEEDF IEEAKVMMKL
     THPKLVQLYG VCTQQKPIYI VTEFMERGCL LNFLRQRQGH FSRDVLLSMC QDVCEGMEYL
     ERNSFIHRDL AARNCLVSEA GVVKVSDFGM ARYVLDDQYT SSSGAKFPVK WCPPEVFNYS
     RFSSKSDVWS FGVLMWEVFT EGRMPFEKYT NYEVVTMVTR GHRLYQPKLA SNYVYEVMLR
     CWQEKPEGRP SFEDLLRTID ELVECEETFG R
//
